Product Information
CITALOPRAM HBR 40 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0420 per EA under NDC 69097082412. Its NADAC has been published 515 times since Oct 12, 2016.
FDA first approved this application on Oct 3, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Cipla USA Inc.NDC
69097082412
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CITALOPRAM HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077534FDA Approved
10/3/2006
TE Code
AB
On Market Since
7/22/2016
Pharmacological Classes
Price Statistics
The NADAC for CITALOPRAM HBR 40 MG TABLET has been published 515 times since Oct 12, 2016, and over the history we have for it it has risen 10.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0420 per EA |
|---|---|
| All-time high | $0.0465 (Nov 13, 2024) |
| All-time low | $0.0347 (Oct 23, 2019) |
| 52-week high | $0.0464 |
| 52-week low | $0.0420 |
| Median price | $0.0395 |
| Average price | $0.0403 |
| Largest weekly change | -23.6% (Nov 20, 2024) |
| Weeks tracked | 515 |
| Tracking since | Oct 12, 2016 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CITALOPRAM HBR 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CITALOPRAM HBR 40 MG TABLET, manufactured by Cipla USA Inc., is $0.0420 per EA (NDC 69097082412), effective Aug 19, 2026.
How has the price of CITALOPRAM HBR 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for CITALOPRAM HBR 40 MG TABLET has risen 10.1%. It has been tracked across 515 weekly CMS publications since Oct 12, 2016.
What are the highest and lowest recorded NADAC prices for CITALOPRAM HBR 40 MG TABLET?
Since Oct 12, 2016, the NADAC for CITALOPRAM HBR 40 MG TABLET has ranged from a low of $0.0347 (Oct 23, 2019) to a high of $0.0465 (Nov 13, 2024), with a median of $0.0395 per EA.
Are there cheaper alternatives to CITALOPRAM HBR 40 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CITALOPRAM HBR 40 MG TABLET, is $0.0355 per EA — about 16% below CITALOPRAM HBR 40 MG TABLET.
Who manufactures CITALOPRAM HBR 40 MG TABLET?
CITALOPRAM HBR 40 MG TABLET (NDC 69097082412) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.